Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine

J Mol Cell Cardiol. 1999 Jan;31(1):275-81. doi: 10.1006/jmcc.1998.0867.


The effect of the highly lipophilic calcium channel antagonist (CCA) amlodipine on membrane oxyradical damage was examined and compared to that of other CCA analogs and a sulfhydryl-containing ACE inhibitor in isolated membrane vesicles enriched with polyunsaturated fatty acids (PUFA). Under physiological-like conditions, the dihydropyridine CCA amlodipine significantly (P<0.001) inhibited lipid peroxide formation (>10(2) microM) at concentrations as low as 10.0 nM. Under identical conditions, inhibition of lipid peroxide formation was not observed with representative CCA analogs (felodipine, verapamil, diltiazem) or the ACE inhibitor, captopril, at concentrations as high as 1.0 microM. The potent antioxidant activity of amlodipine is attributed to distinct membrane physico-chemical interactions. High-resolution differential scanning calorimetry showed that amlodipine effected marked changes in membrane thermodynamic properties as compared to other CCA analogs, including a marked reduction in the thermal phase transition temperature (-2.6 degrees C), enthalpy (-4.8 J/g) and cooperative unit size (-59%), relative to control samples. These findings indicate that the chemical structure of amlodipine contributes to distinct membrane biophysical interactions that lead to potent lipid antioxidant effects, independent of calcium channel modulation. These findings provide insights into potential new mechanisms of action for the charged CCA amlodipine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amlodipine / pharmacology*
  • Amlodipine / therapeutic use*
  • Antihypertensive Agents
  • Antioxidants / therapeutic use*
  • Calcium / antagonists & inhibitors
  • Calorimetry, Differential Scanning
  • Diltiazem / pharmacology
  • Dimyristoylphosphatidylcholine / pharmacology
  • Dose-Response Relationship, Drug
  • Fatty Acids, Unsaturated / metabolism
  • Inhibitory Concentration 50
  • Lipid Peroxidation
  • Phosphatidylcholines / pharmacology
  • Verapamil / pharmacology


  • Antihypertensive Agents
  • Antioxidants
  • Fatty Acids, Unsaturated
  • Phosphatidylcholines
  • Amlodipine
  • 1,2-linoleoylphosphatidylcholine
  • Verapamil
  • Diltiazem
  • Calcium
  • Dimyristoylphosphatidylcholine